开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-08-14 洛洛仔111 来自湖南省

初审差不多两个月，没人审稿，悲剧

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-03-24 zhangqiccmu 来自湖北省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：妇科肿瘤
经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-02-18 扒坏蛋糕来自上海

审稿速度:6.0
偏重的研究方向：胰腺炎
经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-03-22 14862b90m09(暂无昵称) 来自上海

请问各位初审Under Review多久

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-05-16 14697858m50(暂无昵称)

投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考

196 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-12-27 ms1000001212608631 来自上海

挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果

92 0

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2014-02-27 匿名用户

审稿速度:3.0 | 投稿命中率:75.0
经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……

525 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

SCI期刊是如何分区的？

113 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2018-08-13 120ce422m02(暂无昵称)

不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表::
研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表:
两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。
由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。
杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。

欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。

259 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220138, encodeId=cd5e2220138a9, content=初审差不多两个月，没人审稿，悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Wed Aug 14 18:47:33 CST 2024, time=2024-08-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2194959, encodeId=067621949595d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：妇科肿瘤 经验分享：投了第二天旧送审了，2.5送审，3.11悲剧，理由：找了三十个审稿人，没人审稿，真无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0c02582555, createdName=zhangqiccmu, createdTime=Sun Mar 24 03:11:43 CST 2024, time=2024-03-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188004, encodeId=0e802188004e9, content=审稿速度:6.0 偏重的研究方向：胰腺炎 经验分享：审稿速度非常慢，一审2个月，2审3个月还在进行中，且发邮件不回复，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ce1740495, createdName=扒坏蛋糕, createdTime=Sun Feb 18 17:08:21 CST 2024, time=2024-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2121135, encodeId=5b6721211359d, content=请问各位初审Under Review多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf9c5290959, createdName=14862b90m09(暂无昵称), createdTime=Wed Mar 22 16:27:37 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=590987, encodeId=667d59098ec9, content=投了篇生信，被转到别的杂志。最后还是拒绝。写给大家做个参考, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107636, encodeId=b4a2210e6362e, content=挺好的杂志，做外泌体miRNA治疗方向，投了别的五六分期刊都被拒了，投这个至少给外审了，希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Tue Dec 27 10:54:27 CST 2022, time=2022-12-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=501404, encodeId=28c850140423, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个figure，一审周期约3个月，大修三个月后返回很快小修，小修几天返回很快接受，从投稿到接受约5个月左右……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Feb 27 11:19:00 CST 2014, time=2014-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093227, encodeId=8b7a109322e8c, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560053, encodeId=7a06560053e1, content=不选择onlineopen就不收费吗？欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。欢乐的树博士 2017-07-21 15:04:00 发表: 两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。 由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。 杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, beContent=欢乐的树博士 2017-07-21 发表:: 研究方向：药物载体;基因; 接收率：约75% 审稿时间：约2个月两个月内收到审稿意见，审稿人极其认真，提了非常多的宝贵意见，收获很大。由于补充的实验较多，申请了延期修回，编辑很nice，在请求的时间基础上，多给了一周时间。杂志社的效率挺高的，虽然IF不高，也是一次愉快的投稿经历。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0dfa2208657, createdName=120ce422m02(暂无昵称), createdTime=Mon Aug 13 00:00:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093228, encodeId=256010932288b, content=选刊时需结合分区进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

选刊时需结合分区进行吗？

97 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务